About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, April 2nd, 2012

The QualityStocks
Daily Stock List

graphic
graphic

Rosetta Genomics Ltd. (ROSG)

OTCPicks and PennyTrader Publisher reported recently on Rosetta Genomics Ltd. (ROSG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Founded in 2000, Rosetta Genomics Ltd. develops and commercializes a full range of microRNA-based molecular diagnostics. The Company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. The Company is working to develop additional tests in the cancer realm and in other fields, following the launch of five cancer tests since the beginning of 2009. Rosetta Genomics has their laboratories in Philadelphia, Pennsylvania. They have their corporate headquarters and R&D in Rehovot, Israel.

MicroRNAs (miRNAs) are a recently discovered group of short (21–23 nucleotides in length), non-coding genes which regulate the expression of other genes. MicroRNAs have also been shown to have varying expression levels across various pathological conditions. They offer a new class of highly sensitive and tissue specific biomarkers. MicroRNA-based diagnostics may offer physicians and patients an objective tool to accurately identify cancer, predict outcomes and help guide treatment.

The Company has a strong patent position and proprietary platform technologies. Rosetta Genomics is working on the application of these technologies in the development and commercialization of a full range of microRNA-based diagnostic tools. Their miRview product line is commercially available via their Philadelphia-based CAP-accredited, CLIA-certified lab.

Rosetta Genomics' scientists have developed proprietary platform technologies for the identification, extraction, quantification, and analysis of microRNAs from a broad spectrum of sample types. These technologies enable the identification and advancement of multiple diagnostic projects addressing critical unmet needs in cancer, women's health and other indications.

Recently, Rosetta Genomics announced that data from a study investigating the ability of microRNA expression to determine the risk of disease recurrence in colorectal cancer patients was published in the online edition of the International Journal of Oncology. It is expected to appear in the upcoming print edition. The study shows potential for MicroRNAs to determine risk of recurrence in colorectal cancer.

Rosetta Genomics Ltd. (ROSG) closed Monday's trading session at $0.39, down 6.58%, on 95,114 volume with 93 trades.  The average volume for the last 60 days is 371,322.  The 52-week low/high is $0.13/$2.43.

Kobex Minerals, Inc. (KXM)

Today we are reporting on Kobex Minerals, Inc. (KXM), here at the QualityStocks Daily Newsletter.

Kobex Minerals, Inc. formed in September of 2009 by the combination of Kobex Resources Inc., IMA Exploration Inc., and International Barytex Resources Ltd. The Company seeks to identify, acquire, and develop deposits that have the potential to be world class, in the lower cost quartile and in an acceptable risk environment. Kobex Minerals is a Canadian company listed on the Toronto Venture Exchange (KXM.V) and the NYSE Amex Exchange (KXM). The Company has their headquarters in Vancouver, British Columbia.

Kobex Minerals has a highly experienced Board and Management consisting of professionals with significant development and mine management experience. The Company's properties include the Mel Property and the Barb Property.

The 100 percent owned Mel zinc-lead-barite property consists of 257 claims covering 5,380 hectares. The property is in the Watson Lake Mining District of the Yukon. Prospectors first staked the property in 1967. Although the Company has not proposed a current exploration program on the Mel property, further work is warranted and Kobex is currently re-evaluating their strategy on this property. Drilling to test the deeper potential of the Main Mel Zone is also under consideration.  

The Main Mel Zone (as previously disclosed by International Barytex Resources) was the focus of a 48 hole program that resulted in an Indicated Mineral resource of 6.78 million tonnes of 7.1 percent zinc, 2.03 percent lead and 54.69 percent barite. The Main Zone remains open to depth.

The wholly owned Barb property consists of 21 claims (440 hectares). The property is approximately 100 km north of the Town of Watson Lake. Two mineralized zones have undergone identification on the property. These are the Matt Berry and the Money zones.

The Company has not proposed a current exploration program on the Barb property. However, they state that a future exploration program should include a ground geophysical survey program to detail selected airborne geophysical targets. These geophysical anomalies would then undergo testing by diamond drilling. One high priority target is located immediately to the west and parallel to the Money Zone. Kobex is currently re-evaluating their strategy on this property. The Mel and Barb properties have additional exploration potential. This includes geophysical targets that warrant drill testing.

Kobex Minerals, Inc. (KXM) closed Monday's trading session at $0.57, even with yesterday’s close.  The average volume for the last 60 days is 10,090.  The 52-week low/high is $0.54/$1.03.

ARCA biopharma, Inc. (ABIO)

Stock Fortune Teller, StockRich, PennyStockVille, PennyInvest, StockEgg, OTCPennyPicks.com, and OTCNewsAlerts.com reported earlier on ARCA biopharma, Inc. (ABIO), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.

ARCA biopharma, Inc. works to develop genetically targeted therapies for cardiovascular diseases. Their lead product candidate, Gencaro™ (bucindolol hydrochloride), is an investigational, pharmacologically unique beta-blocker and mild vasodilator undergoing development for atrial fibrillation. ARCA biopharma has their headquarters in Broomfield, Colorado.

The Company's business focus combines expertise in cardiovascular pathophysiology, molecular genetics, and clinical development. ARCA has identified common genetic variations that they believe predict individual patient response to Gencaro. This gives it the potential to be the first genetically targeted atrial fibrillation prevention treatment. ARCA is collaborating with Laboratory Corporation of America to develop the companion genetic test for Gencaro.

ARCA is planning to initiate a Phase 3 clinical study of Gencaro in AF patients with heart failure (HF) and left ventricular dysfunction. The Company believes AF is an attractive indication for Gencaro because data from BEST, the previously conducted Phase 3 HF trial involving Gencaro in 2,708 HF patients, suggest Gencaro may have a potentially significant effect in reducing and/or preventing AF.

In January of his year, ARCA biopharma announced that the U.S. Patent and Trademark Office (USPTO) issued a patent on methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient has a specific genotype – homozygous for the arginine 389 polymorphism in the beta-1 adrenergic receptor. The patent (USP# 8,093,286) entitled "Methods for Treatment with Bucindolol Based on Genetic Targeting," provides intellectual property protection in the U.S. for this novel approach to treating patients with bucindolol.

Last week, ARCA biopharma announced results of analyses of atrial fibrillation (AF) data from the BEST trial, a previously conducted Phase 3 heart failure (HF) trial involving Gencaro (bucindolol hydrochloride), in 2,708 advanced heart failure patients. Researchers believe increasing plasma norepinephrine (NE) levels as a measure of adrenergic activity herald worsening of HF in patients with reduced left ventricular ejection fractions (HFREF). Researchers found that Gencaro's norepinephrine lowering properties appear to contribute to its effects in all HFREF patients, but in particular those who have only beta-1 389 arginine receptors.

ARCA biopharma, Inc. (ABIO) closed Monday's trading at $0.91, down 0.01%, on 17,800 volume with 58 trades.  The average volume for the last 60 days is 155,023.  The 52-week low/high is $0.87/$3.20.

Petaquilla Minerals Ltd. (PTQMF)

AllPennyStocks reported recently on Petaquilla Minerals Ltd. (PTQMF), Streetwise Reports did previously, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Petaquilla Minerals Ltd. is a growing, diversified gold producer that lists on the OTC Bulletin Board. The Company's commitment is to maximizing shareholder value through a strategy of efficient production, targeted exploration and select acquisitions. Petaquilla Minerals, via their subsidiaries, engages in the acquisition, exploration, exploration management, and sale of mineral properties in the Republic of Panama. The Company focuses on gold and silver mineralization, as well as other precious metal mineral deposits. Petaquilla Minerals has their headquarters in Vancouver, British Columbia.

The Company operates a surface gold processing plant at their Molejon Gold Project, located in the south central area of their 100 percent owned 842 square kilometer concession land in Panama. This is a region known historically for gold content. The Molejon gold mine reached commercial production in January 2010. It currently operates at the rate of approximately 3,000 tonnes per day with plans to increase production to 5,000 tonnes per day.

In August 2011, Petaquilla Minerals announced the acquisition of Iberian Resources Corp., which brought to the Company development stage projects in Spain with historical resources of 2.1M ounces of gold, 46M oz of silver and significant copper and zinc content. Petaquilla has acquired 100 percent of the Lomero-Poyatos project located in the northeast part of the Spanish/Portuguese (Iberian) Pyrite Belt and several other exploration licenses in Iberia.

This past February, Petaquilla Minerals announced that the Company's subsidiary, Petaquilla Gold, S.A. (Petaquilla), received public recognition from the Panamanian Association of Exporters (APEX), for being the largest exporter of Panama in 2011. At an event held in Panama City, the President of APEX provided Petaquilla with an engraved plaque of honor and congratulated Petaquilla for their contribution to the development and progress of the country.
In addition, in February, Petaquilla Minerals announced that the Company's infrastructure subsidiary, Panama Desarrollo de Infraestructuras, S.A. (PDI Panama) successfully installed their new Metso Crusher 125 mobile crushing system and has been ramping up production. Recently, the new mobile crushing system, composed of a Nordberg NW 125, a GP300S cone, a NW300HPS cone and a DF2016P screen, underwent installation under the supervision of and commissioned by Metso's distributor in Panama.

Petaquilla Minerals Ltd. (PTQMF) closed Monday's session at $0.46, up 2.22%, on 46,200 volume with 15 trades.  The average volume for the last 60 days is 100,685.  The 52-week low/high is $0.46/$1.11.

Liquidmetal® Technologies, Inc. (LQMT)

Jason Bond, OTCPicks, Greenbackers, and PennyTrader Publisher reported recently on Liquidmetal® Technologies, Inc. (LQMT), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Liquidmetal® Technologies, Inc. is a leader in the research, development, and commercialization of amorphous metals. The Company's innovative class of patented alloys and processes form the basis of high performance materials used in an extensive spectrum of medical, military, consumer, and industrial and sporting goods products. Discovered by researchers at the California Institute of Technology, Liquidmetal alloys' unique atomic structure enables applications that were not possible before. Liquidmetal® Technologies has their headquarters in Rancho Santa Margarita, California, along with the Corporate R&D Technology Center.

Liquidmetal alloys have an "amorphous" atomic structure, which is unprecedented for bulk structural metals. They include multi-component chemical compositions optimized for various properties and processes. The Company's metal alloys are the first commercially available metals with process technologies similar to plastics. The technology of Liquidmetal alloys is proprietary and covered by a number of existing or pending patents.

Liquidmetal® Technologies core business focuses on designing, engineering, mold manufacturing, and finishing of complex, precision parts for a broad array of industries. The Company's engineers work in close collaboration with a client's designers, engineers, scientists, and manufacturing staff to create complex, sophisticated designs not possible with other traditional alloys and materials. Liquidmetal has 2-3 times the strength of titanium and stainless steel. It undergoes processing similar to plastics on the Company's proprietary Liquidmetal molding machines.

In late November 2011, Liquidmetal® Technologies announced a strategic partnership with Materion Brush, Inc., a unit of Mayfield Heights, Ohio-based Materion Corp. Materion is a leading worldwide producer of advanced materials and services. As a part of the Certified Liquidmetal Partners Program, Materion will contribute alloy production technologies in partnership with Liquidmetal and other Certified Liquidmetal Partners to ensure that customers are provided consistently high quality products and support services. Materion will produce Liquidmetal alloy materials for use in making customer parts. The partnership will allow Liquidmetal to contribute and collaborate on R&D and take advantage of Materion's extensive production facilities globally.

Last month, Liquidmetal® Technologies announced that their manufacturing operations are currently in the midst of shipping commercial parts to a number of their customers globally. Parts delivery began this past December with continuing shipments scheduled for the months ahead. Additional Liquidmetal Technologies customer parts are scheduled to be part of the manufacturing pipeline in the coming months as the Company continues to ramp their production capabilities.

Liquidmetal® Technologies, Inc. (LQMT) closed Monday at $0.18, down 16.67%, on 4,109,891 volume with 440 trades.  The average volume for the last 60 days is 1,473,366.  The 52-week low/high is $0.11/$0.62.

ProPhase Labs, Inc. (PRPH)

OTCPicks, DrStockPick, and SmallCapVoice reported earlier on ProPhase Labs, Inc. (PRPH), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Founded in 1989, ProPhase Labs, Inc. is a diversified natural health medical science company with corporate headquarters in Doylestown, Pennsylvania. The Company is a leading marketer of the Cold-EEZE® cold remedy brand as well as other cold relief products. ProPhase Labs has a number of wholly owned subsidiaries. This includes a manufacturing unit that consists of an FDA registered facility to manufacture Cold-EEZE® lozenges and fulfill other contract manufacturing opportunities.

In addition, the Company owns 50 percent of Phusion Laboratories, LLC. Phusion licenses an innovative proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds. Phusion will formulate and test products to exploit market opportunities within ProPhase Lab's over-the-counter distribution channels.

ProPhase Labs' Cold-EEZE® zinc gluconate lozenges are clinically proven to reduce significantly the severity and duration of the common cold. Cold-EEZE® customers include leading national retailers, chain food, drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies.

Along with Phusion Laboratories, ProPhase Labs' business units also include Consumer Health and Pharmaloz Manufacturing. The Company's Consumer Health OTC offerings include both the Cold-EEZE® and Kids-EEZE® product lines and the Organix™ cough/cold drops. Pharmaloz is ProPhase Labs' manufacturing and distribution unit. It consists of the aforementioned FDA registered facility. Pharmaloz is FDA and organic certified and manufactures private label lozenges for retail customers in addition to Cold-EEZE and Organix lozenges.

Recently, ProPhase Labs reported net sales of $7.5 million for the three months ended December 31, 2011. This is in comparison to net sales of $6.2 million for the three months ended December 31, 2010. The Company incurred a net loss for the three months ended December 31, 2011, of $1.8 million, or ($0.12) per share, compared to a net loss of $1.1 million, or ($0.08) per share, for the three months ended December 31, 2010.

Results for the fourth quarter of 2011 compared to the fourth quarter of 2010 principally reflect the net effect of an increase in net sales of $1.3 million, offset by an increase in sales and marketing expense of $1.4 million and an increase in research and development costs of $410,000.

ProPhase Labs, Inc. (PRPH) closed Monday's session at $0.95, down 2.06%, on 11,800 volume with 9 trades.  The average volume for the last 60 days is 10,623.  The 52-week low/high is $0.63/$1.59.

Canarc Resource Corp. (CRCUF)

BabyBulls reported recently on Canarc Resource Corp. (CRCUF), Stockhouse News Blast did previously, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Canarc Resource Corp. is a growth-oriented, gold exploration company headquartered in Vancouver, British Columbia. The Company is currently focusing on exploring their four gold properties in central British Columbia and the Tay LP gold property in the Yukon Territory. Canarc is also seeking a partner to advance their 1.1 million oz, high grade, underground, New Polaris gold mine project in British Columbia to the feasibility stage. Canarc Resources lists on the Toronto Stock Exchange (CCM.TO) and the OTCBB (CRCUF).

In 2011, the Company completed an updated NI 43-101 Preliminary Economic Assessment Report for the New Polaris gold mine project in northwestern British Columbia. This significantly enhanced the strong project economics for Canarc to build and operate a 72,000 oz per year gold mine at New Polaris. In addition, the Company amended the Tay LP property option agreement with Ross River Minerals, Inc. to extend the option commitments by one year. Moreover, Canarc identified a number of new exploration targets on the Tay LP property in light of the positive results from the 470-kilometer airborne geophysical survey that Cap-Ex completed in 2010.

In addition, in 2011, Canarc Resources acquired the Windfall Hills project (3,780 hectares) located in central British Columbia approximately 90 km northwest of New Gold's 7.8 million oz Blackwater gold deposit. They defined initial drill targets on the Windfall Hills project by completing a Phase 1 exploration program. This included detailed soil and rock geochemical sampling over the main target area.

Canarc staked three additional gold properties in 2011; called Devils Thumb, Devils Thumb East and Windfall Hills East (15,175 hectares) north and east of the Windfall Hills project.  They also evaluated several attractive merger and acquisition opportunities in order to take the Company to another level of growth in an accretive manner.

Canarc recently received several new expressions of interest from mining companies interested in an option and joint venture to advance New Polaris through mine development and a feasibility study. Company management will continue to focus on trying to close an agreement with a new partner. For 2012, the Company plans to drill several attractive gold targets at the Windfall Hills and Tay LP gold properties. This is subject to securing either option and joint venture partners or appropriate financing.

Canarc Resource Corp. (CRCUF) closed Monday's trading session at $0.20, up 25.00%, on 1,822,743 volume with 184 trades.  The average volume for the last 60 days is 23,083.  The 52-week low/high is $0.08/$0.19.

Strike Graphite Corp. (SRK.V)

Today we are highlighting Strike Graphite Corp. (SRK.V), here at the QualityStocks Daily Newsletter.

Strike Graphite Corp. (formerly Strike Gold Corp.) is an exploration company with experienced management targeting strategic assets on a worldwide scale. The Company is also advancing the Satterly Lake gold project in northwestern, Ontario, located just west of Gold Canyon Resources Inc. Strike Graphite's shares trade on the TSX Venture Exchange. The Company has their headquarters in Vancouver, British Columbia.

Strike Graphite has acquired two projects within a mining friendly, politically stable jurisdiction: Deep Bay East, Saskatchewan and Simon Lake, Saskatchewan. Both projects possess geologic traits for the discovery of significant, large flake graphite deposits. The Deep Bay East Project covers approximately 5,500 hectares (13,590 acres). It is 25 kilometers east of the community of Southend, Saskatchewan and less than 15 kilometers east of the Deep Bay West Graphite Mine. The property is noted for its potential to host a near-surface graphite deposit consisting of scarce, large-flake, high-purity graphite.

The Simon Lake Graphite Project covers 11,800 hectares located approximately 300 kilometers northeast of La Ronge, Saskatchewan. The property consists of several showings of flake graphite mineralization in historic drill holes that underwent discovery during the exploration of base metals. The Company also has their Wagon Property in the Province of Quebec. The Wagon Property consists of three separate claim blocks totaling approximately 3,000 hectares situated within the vicinity (approximately 15 km east) of Timcal's Lac des Iles Graphite Mine, 150 km northwest of Montreal.

Last week, Strike Graphite announced that they received exploration drill permits for their Simon Lake Property in northern Saskatchewan. The permit will allow the Company to begin the ground exploration on the approximately 25 km long conductive horizon that was recently confirmed with a high-resolution airborne TDEM survey.

The design of the next stage of exploration is to confirm with drill testing the known graphite occurrences along the 5.5-km long conductive trend, drill test the new high-priority targets along the recently identified 25 km long conductive trend, and process drill-core material for graphite mineralogical characterization and initial metallurgical testing.

Strike Graphite Corp. (SRK.V) closed Monday's session at $0.42, up 18.57%, on 1,905,779 volume.  The 52-week low/high is $0.10/$0.78.

graphic

The QualityStocks
Company Corner

graphic
graphic

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.007, up 55.56%, on 65,813 volume with 5 trades. The stock’s average daily volume over the past 60 days is 388,461, and its 52-week low/high is $0.001/$0.0205.

Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.

Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.

In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings wholly-owned subsidiary Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming

Consorteum Holdings Completes Acquisition of Tarsin Inc.

Consorteum Holdings, Inc. Announces Lead Spokesman for the First Nations MasterCard Program

SilverSun Technologies, Inc. (SSNT)

The QualityStocks Daily Newsletter would like to spotlight SilverSun Technologies, Inc. (SSNT). Today, SilverSun Technologies, Inc. closed trading at $0.18, even for the day, on 51,018 volume with 15 trades. The stock’s average daily volume over the past 60 days is 10,044, and its 52-week low/high is $0.005/$0.36.

SilverSun Technologies, Inc. (SSNT), via wholly-owned subsidiary SWK Technologies, is a premier total solutions provider specializing in business software for manufacturers and distributors. Established in 1988, the company focuses on meeting the needs of small-sized and mid-sized businesses ("SMB" marketplace) with accounting and business management products, including SilverSun's own proprietary software. The company also offers its own cloud-based solutions and provides network services (network configuration, data backup, 24/7 remote monitoring, etc.) to its clients.

SilverSun distinguishes itself from traditional software resellers by offering a wide range of value-added services, consisting primarily of programming, training, technical support, and other consulting and professional services. The company also provides software customization, data migration, business consulting, and implementation assistance for complex design environments. Currently, the company has over 1,000 active customers.

In addition to driving organic growth, SilverSun's aggressive growth strategy includes acquiring firms in the extensive and expanding SMB marketplace to create substantial value for its shareholders, employees, and partners. SilverSun aims to leverage SWK Technologies as a platform to roll up and aggregate the best and brightest ERP resellers, as well as other software companies with proprietary products that serve the SMB marketplace. The company's most recent acquisition was in January 2012.

In 2011, SilverSun increased sales 40% over the previous year and strengthened its balance sheet through the elimination of all outstanding debt. With organic sales accelerating, significant debt reduction, and great depth of expertise and resources, SilverSun is well positioned to become a dominant player in the growing business software marketplace. Disclaimer

SilverSun Technologies, Inc. Blog

SilverSun Technologies, Inc. News:

SilverSun Technologies Reports Record Revenues and Earnings for Full Year 2011

SilverSun Technologies Signs Letter of Intent to Acquire HighTower

SilverSun Technologies Eliminates Additional $1.3 Million of Debt

TiVUS, Inc. (TIVU)

The QualityStocks Daily Newsletter would like to spotlight TiVUS, Inc. (TIVU). Today, TiVUS, Inc. closed trading at $0.0004, even for the day, on 14,726,000 volume with 17 trades. The stock’s average daily volume over the past 60 days is 26,905,313, and its 52-week low/high is $0.0001/$0.03.

TiVUS, Inc. (TIVU) is a cutting edge provider of information, content distribution, media management and secure communications to the hospitality industry. The company's state of the art digital technology platform and Internet Protocol (IP) infrastructure presents hotels with a valuable opportunity to generate new revenue while enhancing guests' experiences by providing content that is more relevant to their unique interests.

The company's integrated platform stands far beyond the competition, offering unparalleled guest services such as messaging, folio review, express check outs, energy management and other personalized services while providing the traditional services of Free to Guest (FTG) programming, Video-On-Demand programming, a highly secured high speed internet service and many other interactive services such as gaming.

By combining TV and the web world through unparalleled IPTV/HDTV service, hotels are able to generate additional income through commercial spots, advertisements of local tourist services, hotel promotions and more. Features of the platform includes remote administration, support for more than twenty languages, easy installation and a comprehensive hotel services menu capable of providing detailed information about the hotel and upcoming activities, billing information, room service, guest messages and wake-up services.

The system's architecture consists of a Network Operating Center (NOC) and local hotel servers connected through a point-to-point broadband network. As each guest accesses the network, the resulting traffic generated undergoes analysis based on various criteria. This includes behavioral, geographical, seasonality, and more. Using this data, hotels are able to ensure advertisers maximum value for their advertising budget. Disclaimer

TiVUS, Inc. Company Blog

TiVUS, Inc. News:

TiVUS Offers Free-to-Guest Hotel TV Digital Programming

TiVUS' Ad-Insertion Attracts Diverse Range of Advertisers

TiVUS' First Ad-Insertion Revenues Begin - Hotel TV advertising embraced by local merchants

ProGaming Platforms Corp. (PPTF)

The QualityStocks Daily Newsletter would like to spotlight ProGaming Platforms Corp. (PPTF). Today, ProGaming Platforms Corp. closed trading at $0.279, off by 3.46%, on 39,101 volume with 9 trades. The stock’s average daily volume over the past 60 days is 26,266, and its 52-week low/high is $0.115/$0.359.

ProGaming Platforms Corp. (PPTF) specializes in designing, implementing and managing high performance Information Technology Systems ("ITS") infrastructure solutions. Offering national, multi-national and global, turnkey ITS infrastructure solutions, the company is capable of delivery professional services to Fortune 1000 and large multi-site firms as they increasingly single source and outsource to reduce costs while optimizing critical planning, design, program, project and construction management and managed services.

Leveraging standardization, rapid mobilization and a just-in-time professional services approach, Beacon Enterprise Solutions serves as a single source for national, multi-national and global enterprise clients, including special practices focused on data centers, campuses, smart buildings, outside plant, wireless systems and other technology-based applications and projects. Clients are provided with consistent and predictable results anywhere in the world. The company's solutions allow clients to focus on their core businesses without the distraction of having employees spend valuable time on services that Beacon can provide on any continent, in any country using any language.

Headquartered in Louisville, Kentucky, with regional headquarters in Cincinnati, Ohio, Dublin, Ireland, and Prague, Czech Republic, in addition to personnel located throughout the United States and Europe, Beacon Enterprise Solutions services a diverse range of clients. For more than 30 years, the company has enabled businesses in a variety of vertical markets to dramatically reduce costs, enable global standardization, manage day-to-day technology systems moves, adds and changes, and take on major projects – all under a single national, multi-national or global agreement.

Beacon Enterprise Solutions has carefully assembled a seasoned management team and operating strategy to maximize organic growth and new business development across multiple vertical markets. More than 4,000 companies, from small businesses to Fortune 50 firms, have chosen the company's solutions. Disclaimer

ProGaming Platforms Corp. Blog

ProGaming Platforms Corp. News:

ProGaming Platforms Develops Social 3D Flash Game to Showcase Gaming Platform and Capitalize on Online Advertising Opportunities

ProGaming Platforms Issues Letter to Shareholders

ProGaming Platforms Corp. Announces Ten-for-One Forward Stock Split

March Was Another Important Month for FluoroPharma Medical, Inc. (FPMI)

In March, when FluoroPharma Medical, a developer of unique imaging agents for use with positron emission tomography (PET), filed their 10-K for fiscal 2011, there were no surprises, leading Zack’s Investment Research to reaffirm its $2.00 price target and recommendation of “Outperform”. In that same month, FluoroPharma announced that they had signed a letter of intent with SGS Life Sciences to provide clinical research services for Phase II trials of FluoroPharma’s CardioPET imaging agent for determining cardiac viability. It’s an important step for the company, since CardioPET is expected to be one of FPMI’s first products to reach the marketplace, where it would offer a superior alternative to stress testing and represent a major market opportunity.

The three primary products for FluoroPharma are:

• CardioPET – For cardiac viability assessment (detecting regions of metabolic insufficiency)
• BFET – For myocardial perfusion imaging (measuring cardiovascular blood flow)
• VasoPET – For inflamed atherosclerotic plaque imaging (detecting inflamed plaque)

PET technology fills a critical gap in diagnostic imaging, allowing doctors and researchers to see important biochemical processes taking place at the cellular and molecular level, something that other imaging technologies simply cannot match. To do this requires chemical tracers that can integrate themselves into the process being monitored.

There are approximately 12 million PET imaging procedures carried out in the U.S. each year, but currently available PET tracers have significant drawbacks, including high cost, safety issues, and supply shortages. And most of these scans are for the diagnosis of cancer. As a result, there is a growing demand for new radiopharmaceuticals, including tracers for heart imaging such as those under development by FPMI. Basically, FluoroPharm’s drugs improve diagnostic accuracy over existing technologies, improving patient assessment. And it’s not just an American market. Although the U.S. has traditionally been the biggest imaging market, the primary destination today for new PET scanners is China, meaning an increased demand for new tracers.

ENSERVCO Corp. (ENSV) Posts FY, Q4 Financial Results

ENSERVCO, a provider of well-site services to the domestic onshore conventional and unconventional oil and gas industries, today reported financial results for its fiscal year and
fourth quarter ended December 31, 2011.

Full-year revenue increased 32 percent to $24.7 million compared to $18.6 million reported in
2010.

Gross margin for 2011 improved to 24 percent compared to gross margin of 23 percent reported in fiscal 2010.

While adjusted EBITDA for fiscal 2011 improved 47 percent to $3.1 million from $2.1 million reported in 2010, ENSERVCO reported a full-year loss from operations of $2.2 million, or a loss of $(0.09) per share, compared to an operating loss of $2.3 million, or a loss of $(0.10) per share, in 2010.

“We made significant progress in the expansion of our domestic service territory and the build-out of our equipment fleet during 2011, and these efforts helped fuel our top-line growth during the full fiscal year,” Rick Kasch, ENSERVCO president and CFO stated in the press release. “Unfortunately, we just experienced one of the warmest winters on record across much of our
service area, and this severely curtailed fourth-quarter demand for our core heating services. Demand was particularly weak in the Northeast’s Marcellus Shale region, where fourth-quarter revenue declined by approximately 65 percent versus the same period of 2010. In light of stronger demand in the central and north central United States, we redeployed equipment and personnel to these regions in recent months.”

The company’s fourth-quarter revenue increased 6 percent to $6.4 million from $6.0 million in the fourth quarter of 2010.

Gross profit margin was 21 percent versus 28 percent in the 2010 fourth quarter.

ENSERVCO reported a fourth-quarter 2011 operating loss of $1.0 million versus a loss from operations of $41,000 in prior year’s fourth quarter. Net loss was $872,000, or $(0.04) per
diluted share, compared to a net loss of $163,000, or $(0.01) per diluted share, in the same period of 2010.

The company noted adjusted EBITDA for fourth-quarter 2011 was $401,000 compared with $1.1 million in the 2010 fourth quarter.

Xtreme Oil & Gas, Inc. (XTOG) Posts Improved Financial Performance for Fiscal 2011

Xtreme Oil & Gas, an independent energy company engaged in the exploration, development, and production of crude oil, today announced its financial results and operational highlights for fiscal year 2011.

“During the previous year Xtreme Oil & Gas achieved numerous milestones,” Willard G. McAndrew III, CEO of Xtreme stated in the press release. “We are pleased to have achieved an operating profit and excited to utilize these gains in fueling growth across both business lines. Management has successfully transitioned ourselves from a start-up to an emerging oil-producing company with several profitable revenue streams.”

For the 12 months ended December 31, 2011, the company reported revenue of $2.4 million compared to 2010 full-year revenue of $89,835. The company attributes the increase to revenues generated from drilling on its saltwater disposal well and the completion of its Five Star project in Texas.

Oil production expenses for 2011 totaled $194,848 compared to expenses of $241,896 reported for the comparable 12 months of 2010. Loss on disposal of properties totaled $48,356 for the year ended December 31, 2011, directly stemming from the company’s attempts to recover damages on the Lionheart property.

The company reported 2011 net losses before tax of $325,088, or $(0.01) per share on a fully diluted basis, compared with net losses of $7.0 million, or $(0.17) per share on a fully diluted basis, for 2010.

Xtreme said it believes it is useful to consider this non-GAAP measure as it excludes significant one-time accounting charges related to the notes and warrants issued during the third quarter of 2011.

McAndrew III noted the company’s efforts to ramp-up production in a couple properties that are expected to generate continued strength, as well as noted several other operational achievements.

“During 2011 we made investments to increase our production at our Texas and Oklahoma properties that will lead to continued growth in 2012. We also progressed in our high-margin saltwater disposal business and have recently completed construction of our saltwater disposal facility. We have received letters of intent to dispose up to 15,000 barrels of saltwater per day from AMEREX and Southern Wellhead,” McAndrew III stated. “Management believes that this business line will provide an additional $7 million in revenue for each well when it reaches full volume. Recent oil production in Texas and Oklahoma combined with anticipated recovery in Kansas and growth of our salt water disposal business strongly positions us for increased earnings, improved margins, and enhanced shareholder value.”

Wave Systems Corp. (WAVX) Enters Strategic Milestone Distribution Agreement with Vigil Software

Wave Systems has established a strong position in enterprise network endpoint encryption technologies, with offerings like the EMBASSY® Remote Administration Server (ERAS) that gives businesses a powerful solution to costly, time-consuming, full-disk encryption (FDE) methods like deploying self-encrypting drives (SEDs) across enterprise laptops or other hardware. Moving to exploit this enviable market position, the company has entered a key partnership with award-winning UK-based IT security distributor Vigil Software Ltd., as part of the company’s strategic channel expansion targeting Europe, Middle East, and Africa (EMEA), Wave Systems is putting their full portfolio of industry-leading solutions before EMEA markets via this distribution agreement.

Vigil used to be a distribution partner for Safend, which is now part of WAVX with its own division, offering the Safend Data Protection Suite for securing endpoint data, making them the perfect company to act as a distribution node to meet the swelling demand in EMEA markets for Wave’s portfolio of products. Vigil is fully authorized under this new agreement to distribute the entire suite of WAVX offerings and will likely be put to the test getting the mission-critical endpoint data security, data-in-motion, and hardware-based two-factor authentication solutions (which use an advanced Trusted Platform Module architecture) into the hands of eagerly awaiting businesses in the EMEA region.

Founder of Vigil Software, Alex Teh, emphasized the rapidly increasing sophistication and frequency of cyber-attacks which have left conventional software security solutions highly vulnerable, clearly pleased to be offering Vigil’s vast network of resellers the WAVX platform that features powerful embedded security solutions. Encryption, retention, and authentication just got a whole lot easier, especially for UK enterprises, who will feel the most immediate impact of this important agreement.

VP of Channels at WAVX, Mony Bulocinic, was excited to see the prospects develop for this partnership and reminded investors of the possible momentum generated in EMEA markets via this systematic push by the company to expand channel focus, offering these low hanging fruits “best-in-class managed encryption and authentication solutions” to meet emerging security requirements. Bulocinic underscored Vigil’s huge network resellers and specialists, well versed in the security market and able to make this agreement pay off for both companies with highly-focused sales opportunities that are custom tailored to client needs.

It is a serious strategic push by WAVX into sectors ripe for the picking, with vast swathes of enterprises that want to migrate to a tighter data security profile but lack the option/availability. Rapidly growing data security sectors in all primary targets and a winning solution set are very positive indicators for WAVX as this move to secure a broad channel distribution arrangement with Vigil heats up.

The ERAS provides a single console for easily managing an entire fleet of SEDs and WAVX provides automated, turn-key administration of native Win7 Microsoft encryption, employing Safend Encryptor for software encryption tasks, as well as data-in-motion/removable media encryption. Leveraging the hardware-based chip encryption framework of the SED architecture, WAVX software shields critical data from attacks much better and faster than extant software encryption solutions, while enabling full system control. Everything from drive initialization/locking to user management/recovery, with crypto erase for all Opal-based, proprietary and solid-state SEDs.

The ERAS Safend suite includes Protector/Inspector for shunting unauthorized users, devices or malware, sealing physical ports, wireless interfaces, and removable media via an advanced classification hierarchy (using model, serial number, and resident inspection/classification engine capabilities) that cauterizes data leakage through email and file transfer/control. Total transparency of the hardware Trusted Platform Module security chips via Wave Endpoint Monitor allows customers to slam Advanced Persistent Threats, sniffing out unauthorized changes to the pre-boot environment as the systems power up.

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

HotShotStocks
(HBRM)

2.

StockMister
(GTRL)

3.

OTCPicks
(EVCA)

graphic
By The Numbers Charts
QualitystockTwits

Daily Sponsors

The QualityStocks By The Numbers Report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251